139 related articles for article (PubMed ID: 12101569)
1. [Toxicity and antitumoral activity of two new complex compounds of rhenium].
Natorkhin MI; Stukov AN; Filov VA
Vopr Onkol; 2002; 48(1):61-2. PubMed ID: 12101569
[TBL] [Abstract][Full Text] [Related]
2. Antitumor metallocenes: new developments and toxicologic features.
Köpf-Maier P; Köpf H
Anticancer Res; 1986; 6(2):227-33. PubMed ID: 3707060
[TBL] [Abstract][Full Text] [Related]
3. Chiral cyclopalladated complexes derived from N,N-dimethyl-1-phenethylamine with bridging bis(diphenylphosphine)ferrocene ligand as inhibitors of the cathepsin B activity and as antitumoral agents.
Bincoletto C; Tersariol IL; Oliveira CR; Dreher S; Fausto DM; Soufen MA; Nascimento FD; Caires AC
Bioorg Med Chem; 2005 Apr; 13(8):3047-55. PubMed ID: 15781414
[TBL] [Abstract][Full Text] [Related]
4. Cytotoxicity of rhenium(I) alkoxo and hydroxo carbonyl complexes in murine and human tumor cells.
Yan YK; Cho SE; Shaffer KA; Rowell JE; Barnes BJ; Hall IH
Pharmazie; 2000 Apr; 55(4):307-13. PubMed ID: 10798247
[TBL] [Abstract][Full Text] [Related]
5. Development of differential cytotoxic compounds containing nitrosourea and benzothiazine nucleus.
Nyati MK; Rai D; Gupta RR; Dev PK
In Vivo; 1997; 11(1):95-9. PubMed ID: 9067778
[TBL] [Abstract][Full Text] [Related]
6. The influence of three newly synthesized pyrimidine-containing compounds on micronucleus induction and tumor growth.
Nersesyan A; Muradyan R; Arsenyan F
J BUON; 2007; 12(4):521-7. PubMed ID: 18067211
[TBL] [Abstract][Full Text] [Related]
7. Antitumor properties of boron complexes with hydroxy biguanide and salicyl hydroxamic acid against Ehrlich ascites carcinoma.
Ghosh P; Bag SP; Sur B; Sur P
Neoplasma; 1998; 45(2):68-72. PubMed ID: 9687884
[TBL] [Abstract][Full Text] [Related]
8. Ionic rhenocene derivatives with antitumor activity.
Köpf-Maier P; Klapötke T
Cancer Chemother Pharmacol; 1992; 29(5):361-6. PubMed ID: 1551174
[TBL] [Abstract][Full Text] [Related]
9. Antitumor activity of the mixed phosphine gold species chlorotriphenylphosphine-1,3-bis(diphenylphosphino)propanegold(I).
Caruso F; Rossi M; Tanski J; Pettinari C; Marchetti F
J Med Chem; 2003 Apr; 46(9):1737-42. PubMed ID: 12699391
[TBL] [Abstract][Full Text] [Related]
10. Antitumor activity of a new platinum(II) complex with low nephrotoxicity and genotoxicity.
Marzano C; Bettio F; Baccichetti F; Trevisan A; Giovagnini L; Fregona D
Chem Biol Interact; 2004 Jun; 148(1-2):37-48. PubMed ID: 15223355
[TBL] [Abstract][Full Text] [Related]
11. The primary cultures of animal ascites tumor cells growth in tubes in suspension as a model in the screening of antitumor agents.
Ivanitskaya LP; Makukho LV
Neoplasma; 1975; 22(1):105-7. PubMed ID: 1153034
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the anti-neoplastic effects of dirhodium(II) tetrapropionate and its adducts with nicotinate and isonicotinate anions in mice bearing Ehrlich tumors.
de Souza AR; Coelho EP; Zyngier SB
Eur J Med Chem; 2006 Oct; 41(10):1214-6. PubMed ID: 16822594
[TBL] [Abstract][Full Text] [Related]
13. The first organoantimony(III) compounds possessing antitumor properties: diphenylantimony(III) derivatives of dithiophosphorus ligands.
Silvestru C; Socaciu C; Bara A; Haiduc I
Anticancer Res; 1990; 10(3):803-4. PubMed ID: 2369094
[TBL] [Abstract][Full Text] [Related]
14. Ascitic and solid Ehrlich tumor inhibition by Chenopodium ambrosioides L. treatment.
Nascimento FR; Cruz GV; Pereira PV; Maciel MC; Silva LA; Azevedo AP; Barroqueiro ES; Guerra RN
Life Sci; 2006 Apr; 78(22):2650-3. PubMed ID: 16307762
[TBL] [Abstract][Full Text] [Related]
15. [An analysis of the connection between the inhibition of NAD biosynthesis and the antitumor activity of drugs].
Reztsova VV; Filov VA; Stukov AN
Vopr Onkol; 1992; 38(6):718-23. PubMed ID: 1300772
[TBL] [Abstract][Full Text] [Related]
16. Central action of sanumgerman administered orally in mice.
Kleinrok Z; Lekim D; Jagiełło-Wójtowicz E
Acta Physiol Pol; 1988; 39(4):244-53. PubMed ID: 3252687
[TBL] [Abstract][Full Text] [Related]
17. [New amino acid derivatives with oncolytic action].
Zangger J
Krebsarzt; 1969; 24(6):347-63. PubMed ID: 4143639
[TBL] [Abstract][Full Text] [Related]
18. [The inhibitory effects of Realgar bioleaching solution on S180 ascites-tumor and its toxicity].
Xie QJ; Zhang X; Wang X; Bai L; Li HY
Zhong Yao Cai; 2009 Jun; 32(6):933-6. PubMed ID: 19764334
[TBL] [Abstract][Full Text] [Related]
19. Potential new antitumor agents from an innovative combination of camphorato, a ramification of traditional Chinese medicine, with a platinum moiety.
Wang L; Gou S; Chen Y; Liu Y
Bioorg Med Chem Lett; 2005 Jul; 15(14):3417-22. PubMed ID: 15953727
[TBL] [Abstract][Full Text] [Related]
20. Dichlorotetra-mu-Isobutyratodirhenium(III): enhancement of cisplatin action and RBC-stabilizing properties.
Shtemenko N; Collery P; Shtemenko A
Anticancer Res; 2007; 27(4B):2487-92. PubMed ID: 17695543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
